[Ketum "forces" its way back on the market. What is the price of a serious adverse event?]

Ann Dermatol Venereol. 2010 Mar;137(3):175-6. doi: 10.1016/j.annder.2010.02.005.

[Article in French]

Authors

J-C Beani, M Avenel-Audran, A Barbaud, J Revuz

PMID: 20227557
DOI: 10.1016/j.annder.2010.02.005

No abstract available

Publication types

Editorial

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
Drug Approval*
France
Humans
Ketoprofen / adverse effects*
Photosensitivity Disorders / chemically induced*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Ketoprofen